{"id":1732,"date":"2021-09-10T11:17:40","date_gmt":"2021-09-10T09:17:40","guid":{"rendered":"https:\/\/www.eurotranspharma.com\/?p=1732"},"modified":"2023-02-21T15:43:41","modified_gmt":"2023-02-21T14:43:41","slug":"eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools","status":"publish","type":"post","link":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/","title":{"rendered":"Eurotranspharma is developing its infrastructure and investing in new tools"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” equal_height=”yes” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_color=”#ffffff” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” advanced_gradient_angle=”0″ overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” advanced_gradient_angle=”0″ gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid” gradient_type=”default”][split_line_heading animation_type=”line-reveal-by-space” font_style=”h2″ text_color=”#7194af” line_reveal_by_space_text_effect=”default” content_alignment=”default” mobile_content_alignment=”inherit” link_target=”_self” text_content=”Eurotranspharma is developing its infrastructure and investing in new tools to meet the growing demands of its customers.”][\/split_line_heading][image_with_animation image_url=”1727″ image_size=”full” animation_type=”entrance” animation=”None” animation_movement_type=”transform_y” hover_animation=”none” alignment=”” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][vc_column_text]As the leading European carrier 100% dedicated to the transport of health products, and compliant with Good Distribution Practices, Eurotranspharma has been developing a transformation plan for its infrastructure in France since the beginning of 2020, with the aim of further improving its quality of service, traceability, and the safety of the health products it handles. This involves construction, upgrading the pharmaceutical vehicle fleet, and the deployment of new digital tools.<\/p>\n

With a national network of 19 warehouses, including 4 hubs 100% dedicated to health products and controlled temperature, Eurotranspharma has chosen to invest in its buildings in order to modernise them, to increase its operational capacities in 15\/25\u00b0C, and to have operating areas entirely under controlled temperature to meet the strong demand of its customers. The increase of the operating surface in controlled temperature is a key asset of the Eurotranspharma network, ensuring the safety of the health products in transit in the hubs and warehouses.<\/p>\n

Following the renovation of the Cr\u00e9teil branch in March 2020, it is now the Dijon branch\u2019s turn to get a facelift, with both the modernisation of the existing infrastructure and the construction of an extension. The Dijon branch\u2019s operating area will be increased from 500m\u00b2 to 1,525m\u00b2 under temperature control in 2\/8\u00b0C and 15\/25\u00b0C.<\/p>\n

In operation now since June 21, 2021, this new structure also allows Eurotranspharma to strategically reinforce its presence in the Jura and Sa\u00f4ne and Loire departments. 6 other renovation and construction projects are planned between now and the end of 2022.[\/vc_column_text][vc_column_text]In addition, the modernisation of the Eurotranspharma network is taking into account the implementation of innovative digital solutions such as :<\/p>\n

– \u201cconsignee certification\u201d, which allows secure delivery directly to the patient using a unique code,
\n– the implementation of the \u201ccontrol tower\u201d, a device allowing the centralised monitoring in real time of temperatures on all vehicles and different systems, the creation
\n– an e-learning platform to reinforce the current training in good practices for the distribution of pharmaceutical products, as well as quality monitoring for all of the network\u2019s participants.
\n– The final digital solution is Atlas, a European TMS, validated by GDP, supporting all of Eurotranspharma\u2019s loading, planning, sorting, delivery, monitoring, and traceability operations for all movements.
\nIn addition, Eurotranspharma is working on an environmental transition plan with the acquisition of several vehicles running on Bio CNG (Bio gas from methanisation).<\/p>\n

All these modernisations are in line with the increasingly high requirements of the Good Distribution Practice applied in pharmaceutical distribution, and particularly needed during the transport of Covid or Flu vaccines, the campaign for which will start soon.<\/p>\n[\/vc_column_text][vc_column_text]\n

About Eurotranspharma<\/strong><\/h3>\n

Eurotranspharma is the leading European multi-country carrier 100% dedicated to healthcare products. In conformity with the GDP standards, Eurotranspharma delivers healthcare products in a temperature-controlled environment ( 2-8 \u00b0C \/ 15-25 \u00b0C ). Owing to its IT connected tools, Eurotranspharma provides top-quality last mile distribution with the full end-to-end traceability that healthcare products require. The company operates in France, Belgium, the Netherlands, Luxemburg, the Czech Republic and Slovakia with a fleet of 800 vehicles and 1000 specially trained & committed staff.<\/p>\n

For more information, please contact:<\/strong>
\nLaure Murat \u00ad| Marketing and Communication<\/p>\n

Walden Group<\/p>\n

laure.murat@walden-group.com[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” equal_height=”yes” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_color=”#ffffff” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” advanced_gradient_angle=”0″ overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default”…<\/p>\n","protected":false},"author":3,"featured_media":5415,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-1732","post","type-post","status-publish","format-standard","has-post-thumbnail","category-eurotranspharma"],"yoast_head":"\nEurotranspharma is developing its infrastructure and investing in new tools - EUROTRANSPHARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eurotranspharma is developing its infrastructure and investing in new tools - EUROTRANSPHARMA\" \/>\n<meta property=\"og:description\" content=\"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” equal_height=”yes” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_color=”#ffffff” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” advanced_gradient_angle=”0″ overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default”...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/\" \/>\n<meta property=\"og:site_name\" content=\"EUROTRANSPHARMA\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-10T09:17:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-21T14:43:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2021\/12\/Capture-decran-2023-02-21-152454.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1230\" \/>\n\t<meta property=\"og:image:height\" content=\"687\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Olha Hlias\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Olha Hlias\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/\"},\"author\":{\"name\":\"Olha Hlias\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c752465ad6b1ea4d80bb1d6cf53f6fea\"},\"headline\":\"Eurotranspharma is developing its infrastructure and investing in new tools\",\"datePublished\":\"2021-09-10T09:17:40+00:00\",\"dateModified\":\"2023-02-21T14:43:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/\"},\"wordCount\":814,\"image\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Capture-decran-2023-02-21-152454.jpg\",\"articleSection\":[\"Eurotranspharma\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/\",\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/\",\"name\":\"Eurotranspharma is developing its infrastructure and investing in new tools - EUROTRANSPHARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Capture-decran-2023-02-21-152454.jpg\",\"datePublished\":\"2021-09-10T09:17:40+00:00\",\"dateModified\":\"2023-02-21T14:43:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c752465ad6b1ea4d80bb1d6cf53f6fea\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Capture-decran-2023-02-21-152454.jpg\",\"contentUrl\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Capture-decran-2023-02-21-152454.jpg\",\"width\":1230,\"height\":687},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eurotranspharma is developing its infrastructure and investing in new tools\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/\",\"name\":\"EUROTRANSPHARMA\",\"description\":\"Healthcare Distribution Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c752465ad6b1ea4d80bb1d6cf53f6fea\",\"name\":\"Olha Hlias\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g\",\"caption\":\"Olha Hlias\"},\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/en\\\/author\\\/eab298f685c00616\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eurotranspharma is developing its infrastructure and investing in new tools - EUROTRANSPHARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/","og_locale":"en_US","og_type":"article","og_title":"Eurotranspharma is developing its infrastructure and investing in new tools - EUROTRANSPHARMA","og_description":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” equal_height=”yes” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_color=”#ffffff” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” advanced_gradient_angle=”0″ overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” gradient_type=”default” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default”...","og_url":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/","og_site_name":"EUROTRANSPHARMA","article_published_time":"2021-09-10T09:17:40+00:00","article_modified_time":"2023-02-21T14:43:41+00:00","og_image":[{"width":1230,"height":687,"url":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2021\/12\/Capture-decran-2023-02-21-152454.jpg","type":"image\/jpeg"}],"author":"Olha Hlias","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Olha Hlias","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#article","isPartOf":{"@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/"},"author":{"name":"Olha Hlias","@id":"https:\/\/www.eurotranspharma.com\/en\/#\/schema\/person\/c752465ad6b1ea4d80bb1d6cf53f6fea"},"headline":"Eurotranspharma is developing its infrastructure and investing in new tools","datePublished":"2021-09-10T09:17:40+00:00","dateModified":"2023-02-21T14:43:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/"},"wordCount":814,"image":{"@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2021\/12\/Capture-decran-2023-02-21-152454.jpg","articleSection":["Eurotranspharma"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/","url":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/","name":"Eurotranspharma is developing its infrastructure and investing in new tools - EUROTRANSPHARMA","isPartOf":{"@id":"https:\/\/www.eurotranspharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#primaryimage"},"image":{"@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2021\/12\/Capture-decran-2023-02-21-152454.jpg","datePublished":"2021-09-10T09:17:40+00:00","dateModified":"2023-02-21T14:43:41+00:00","author":{"@id":"https:\/\/www.eurotranspharma.com\/en\/#\/schema\/person\/c752465ad6b1ea4d80bb1d6cf53f6fea"},"breadcrumb":{"@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#primaryimage","url":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2021\/12\/Capture-decran-2023-02-21-152454.jpg","contentUrl":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2021\/12\/Capture-decran-2023-02-21-152454.jpg","width":1230,"height":687},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurotranspharma.com\/en\/eurotranspharma-is-developing-its-infrastructure-and-investing-in-new-tools\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurotranspharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Eurotranspharma is developing its infrastructure and investing in new tools"}]},{"@type":"WebSite","@id":"https:\/\/www.eurotranspharma.com\/en\/#website","url":"https:\/\/www.eurotranspharma.com\/en\/","name":"EUROTRANSPHARMA","description":"Healthcare Distribution Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurotranspharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.eurotranspharma.com\/en\/#\/schema\/person\/c752465ad6b1ea4d80bb1d6cf53f6fea","name":"Olha Hlias","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g","caption":"Olha Hlias"},"url":"https:\/\/www.eurotranspharma.com\/en\/author\/eab298f685c00616\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/posts\/1732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/comments?post=1732"}],"version-history":[{"count":5,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/posts\/1732\/revisions"}],"predecessor-version":[{"id":2524,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/posts\/1732\/revisions\/2524"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/media\/5415"}],"wp:attachment":[{"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/media?parent=1732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/categories?post=1732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/en\/wp-json\/wp\/v2\/tags?post=1732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}